PROTECTIVE EFFECT OF CUMIN (CUMINUM CYMINUM L.) SEED EXTRACT ON CARDIOVASCULAR SYSTEM, TOXICITY, AND HEMATOLOGY ON HYPERLIPIDEMIC RABBITS: AN EXPERIMENTAL STUDY by Chouhan, Harshlata & Purohit, Ashok
Vol 11, Issue 10, 2018
Online - 2455-3891 
Print - 0974-2441
PROTECTIVE EFFECT OF CUMIN (CUMINUM CYMINUM L.) SEED EXTRACT ON 
CARDIOVASCULAR SYSTEM, TOXICITY, AND HEMATOLOGY ON HYPERLIPIDEMIC  
RABBITS: AN EXPERIMENTAL STUDY
HARSHLATA CHOUHAN*, ASHOK PUROHIT
Department of Zoology, Jai Narayan Vyas University, Jodhpur, Rajasthan, India. Email: harshlata.chouhan@gmail.com
Received: 18 May 2018, Revised and Accepted: 22 June 2018
ABSTRACT
Objective: The present study is related with the assessment of anti-atherosclerotic efficacy of 70% EtOH extract of cumin seed in diet-induced 
hyperlipidemic rabbits.
Methods: Rabbits were rendered hyperlipidemic by oral administration of cholesterol for 15 days. Then, the animals were treated with 70% EtOH 
(ethanolic extract) of cumin seed extract for 45 days (Group III). Another set of animals was treated with atorvastatin, the standard drug for 45 days. 
At the end of experimental period, the serum biochemical, hematological, and histological analysis of thoracic aorta was done.
Results: The cumin seed extract showed contain hypolipidemic effect by reducing plasma cholesterol, low-density lipoproteins, and triglycerides 
level. While toxicological studies suggest no adverse effect on renal and liver function tests, hematological parameters were also observed in a normal 
range. Histological analysis showed that cholesterol administration caused a narrowing of the aortal lumen while treatment with 70% EtOH and 
atorvastatin decreased the plaque size and restored the luminal size of the aorta to normal.
Conclusion: The present study suggests that commonly used culinary spice cumin seed possesses hypolipidemic and cardioprotective effect with a 
positive effect on serum biochemistry, histology, and hematology.
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INTRODUCTION
Atherosclerosis underlies the leading reason of mortality and morbidity 
globally. Initiation of atherosclerosis involves a decade-long expansion 
of the arterial intima, which occurs due to an intricate interaction of 
circulatory factors and various cell types in the vessel wall including 
endothelial cells, lymphocytes, monocytes, and smooth muscle 
cells [1]. Cardiovascular disease (CVD) causes 1 of every 5 deaths in 
past years [2]. Current allopathic drug treatment for atherosclerosis 
involves statin (HMG-Co-A reductase inhibitors), fibrates, niacin, and 
bile acid resins. Among these remedies, the statin is the most widely 
and reliably used drug as it directly lowers the serum cholesterol 
level by competitively inhibiting HMG-CoA reductase enzyme in the 
liver [3]. However, as the main end product of HMG-CoA activity is 
mevalonate, which acts as a precursor of many other non-steroidal 
isoprenoid compounds, so the inhibition of this enzyme results in 
pleiotropic effects and thus long-term consumption of statin causes 
several side effects [4]. Side effects of statin are labeled as statin-
associated symptoms which include muscular damage (statin-
associated muscle symptoms), rarely rhabdomyolysis, statin-induced 
narcotizing myopathy, diabetes mellitus, Alzheimer’s, and dementia [5]. 
If the condition of atherosclerosis goes more severe, the patients are 
suggested to undergo cardiovascular surgery. Cardiovascular surgery 
is an important treatment [6], but these surgical alternatives are very 
expensive. Hence, there is a need to find an effective, reliable drug with 
less or none side effects and the answer relies on herbal medicines. 
Studies suggest that 4 billion people (about 80% population) prefer 
herbal medicines for some aspects of primary health care [7]. Dietary 
plants and their ingredients can act effectively for the management of 
hyperlipidemia as they have been reported to possess lipid digestion 
and absorption inhibiting constituents [8]. In traditional medicinal 
system, aromatic plants have always been important and being used 
for a long time [9]. Cuminum cyminum Linn. is one of the important 
culinary, aromatic plants used as primary medicine for a long time. The 
present work is focused on exploring the cardioprotective and anti-
atherosclerotic effect of cumin seed extract on cholesterol-fed rabbits.
METHODS
Extraction of plant material
Dried and cleaned seeds of the C. cyminum (Linn.) were bought from 
the local market. 70% of ethanolic extract was prepared with the use of 
Soxhlet apparatus for 24 h. The extract was treated under low pressure 
and temperature and then distilled to remove excess of ethanol from 
the extract. After complete removal of ethanol from the extract, it was 
dried to obtain the brown-colored sticky extract. The extract was stored 
in desiccation for future use in experiments.
Experimental animals
New Zealand white rabbits weighing between 1 and 1.25 kg were 
obtained from the certified institute. Animals were acclimatized for 
10 days before the onset of the experiment. Animals were kept in clean, 
metallic wire gauge cages in a room with 12:12 h light-dark cycle, 20–
25°C temperature, and 40–50% relative humidity and were fed with 
standard pellet diet and fresh green vegetables and drinking water. The 
experimental protocol was approved by the Institutional Animal Ethical 
Committee (Reg No.: 1646/GO/Re/12/CPCSEA).
Experimentation
Induction of hyperlipidemia
Rabbits were rendered hyperlipidemic by the oral dose of cholesterol 
powder at the dose of 500 mg/kg.b.wt./day dissolved in 5 ml of coconut 
oil for 15 days.
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Dose regimen of atorvastatin
Atorvastatin (Atorlip-10, Cipla) was used as a standard hypolipidemic 
drug. It was orally administrated at the dose of 0.25 mg/kg.b.wt./day 
dissolved in 5 ml of distilled water.
Preparation of plant drug
70% of ethanolic extract (500mg/kg b.wt.) was then given to the 
experimental animals by mixing it in 5 ml distilled water. The dose of 
the extract was determined by LD50 test.
Experimental design
The experimental period was of 60 days and divided into four groups 
(n=5).
Group I: Intact control
Group II: Hyperlipidemic control
Group III: 70% EtOH of cumin seed treatment group
Group IV: Atorvastatin (Atorlip-10) treatment group.
Assessment of hematology
Blood was collected by direct cardiac puncture at the end of 
experimental period. The collected blood was stored in EDTA vials at 
−20°C. Hematological assessments of hemoglobin, TRBC, hematocrit, 
mean corpuscular volume, mean cell hemoglobin, mean corpuscular 
hemoglobin concentration, red cell distribution width, total leukocyte 
count, platelet count, plateletcrit, mean platelet volume, and platelet 
distribution width were examined using hematology analyzer through 
standard methods [10].
Assessment of serum biochemistry
At the end of experimental period, animals were sacrificed under 
prolonged anesthesia and direct cardiac puncture. Serum was separated 
by centrifugation of blood at 3000 rpm for 15 min and stored at −20°C 
for further need. Serum samples were analyzed using Biochem Auto-
analyzer RX-50 (Microlab Instrument) for total cholesterol (TC), high-
density lipoprotein-cholesterol (HDL-C), and triglycerides (TGs) using 
commercial diagnostic kits (Siemens Healthcare Diagnostics, USA). 
Low-density lipoprotein (LDL)-cholesterol and very-LDL (VLDL-C) 
were calculated by Friedewald’s formula [11]. TC/HDL and LDL/HDL 
were also calculated as ischemic indices to access the atherogenic risk. 
The toxicity profile was also performed by standard kits [12].
Histopathology of the aorta
The thoracic aorta was cut (2–3 cm length) and excised from the 
heart. The tissue was cleaned in 0.9% saline and kept in 10% formalin 
fixative. The processed aorta was then ultrasectioned (5–6 μm 
thickness). Sectioned tissues were stained with hematoxylin and eosin 
stain and examined under the light microscope for histopathological 
observations.
Statistical analysis
All biochemical parameters were expressed as the mean±standard 
error of the mean. One-way ANOVA was analyzed using Tukey’s multiple 
comparison tests. GraphPad Prism-7 was used for data analysis, and 
graphical representation was made using MS Excel-2007. Level of 
significance was expressed as p<0.05.
RESULTS
Effect on lipid profile
A drastic increase in serum TC was observed when high cholesterol 
diet was administered to the animals, and this increase in TC was 
decreased significantly 85% (p≤0.01) in animals treated with 70% 
EtOH of cumin seed extract. While highly significant (p≤0.001) increase 
in HDL-C concentration was observed in the hyperlipidemic group, this 
level came back down when treated with 70% EtOH cumin seed extract 
and statin. Similarly, in the case of LDL-C, 96%, in VLDL-C, 39.61%, 
and in TG, 64.08% reduction were observed in cumin seed extract-
treated groups which are comparable with statin treatment. CHOL/
HDL and HDL/LDL ratio of both 70% EtOH cumin seed extract and 
statin-treated groups were comparable with the control group. Total 
lipid concentration also showed high significant (83.69%) increase 
in case of the hyperlipidemic group, while other two groups showed 
significant decrease, and 74.78% in cumin extract treated and 81.88% 
in atorvastatin-treated groups were observed.
Effect on serum biochemistry
Serum biochemical analysis suggests that there is a considerable increase 
in the level of blood sugar in the hyperlipidemic group while cumin seed 
extract and atorvastatin-treated animals showed almost normal values 
near to the control group. Some of the other parameters of the liver 
functional test and the renal function test did not show any considerable 
variation throughout the experimental period in all the four groups.
Effect on hematology
Observations suggest that no noticeable variation was observed in 
hematological parameters. All the parameters were near the control values.
Effect on aortic plaque formation (Figs. 1 and 2, Tables 1 and 2)
Histopathological study of ascending aorta shows plaque formation 
with the presence of foam cells, collagen, and lipid deposition causing 
thickened intimal lining, resulting in narrowing of the arterial lumen, 
Fig. 1: Graphical representation of the effect of 70% EtOH extract 
of cumin seed-treated hyperlipidemic rabbits. (Mean of five 
values±standard error of the mean)
Fig. 2: Photomicrographs (H and E stain, 100×) of thoracic aorta of 
treated rabbits – (a) intact control: Thoracic aorta showing normal 
histology with aortic wall consisting of tunica adventitia, tunica 
media, and tunica intima. (b) Hyperlipidemic: Thoracic aorta 
exhibiting endothelium with the formation of atherosclerotic 
plaque which has thickened intima with large number of 
foam cells. (c) Cumin extract treated: Aorta showing normal 
histoarchitecture with restoration in endothelial wall integrity. (d) 
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while treatment with 70% EtOH extract of cumin seed showed a 
significant reduction in plaque size and restoration of arterial wall 
integrity. These findings were comparable to atorvastatin-treated groups.
DISCUSSION
Diet with a high level of cholesterol and fat has shown to promote the 
progression of atherosclerosis [13,14]. Major risk factors for coronary 
heart disease include hypercholesterolemia, hypertension, cigarette 
smoking, diabetes, and high cholesterol-rich and fat diet, which eventually 
result in impairment of endothelial function which further develops 
atherosclerosis [13,15]. It is well established that hyperlipidemia is one 
of the major risk factors in CVD, including atherosclerosis. Managing 
hyperlipidemia as a way to prevent atherosclerosis is a common activity 
in the treatment of this disease [16]. Current treatment therapies treat the 
disease either by lowering the cholesterol production through inhibition 
of HMG-CoA reductase enzyme in liver (like statins) or by lowering 
serum TG level (like fibrates) or by increasing apo-A-1 containing 
lipoproteins (like niacin) [17], but all these treatment drugs leave a large 
burden of residual untreated disease [18,19]. Excess administration 
of cholesterol results in the occurrence of hypercholesterolemia and 
atherosclerosis [20]. In the present experiment, high cholesterol diet 
administration caused increased concentration of serum TC, LDL-C, 
VLDL, and TG level. These findings were also observed in another study 
in which animals respond to the atherogenic diet with a significant 
increase in total plasma cholesterol concentration [21]. Elevated level 
of LDL-C, VLDL, and TG plays a vital role in plaque formation. LDL 
and their modified forms and serum TG have a harmful effect on the 
musculature of endothelium [22]. Accumulation of lipid is the first 
necessity for the plaque formation, lipid deposition initiates with the 
movement of LDL-C from the blood into the vessel wall [23], while 
LDL has a fundamental physiological role as a vehicle for the delivery 
of cholesterol, and its high concentration in bloodstream is associated 
with increased risk of CVD [2]. Statins are among the most prescribed 
class of medication used in the last couple of years. The beneficial effect 
of statin is due to their capacity of reducing cholesterol biosynthesis 
mainly in the liver, by competitively inhibiting HMG-CoA reductase 
enzyme [4,24]. Raised lipid-lowering effect of 70% EtOH extract of 
cumin seed was comparable to that of atorvastatin. Cumin seed has the 
cholesterol-lowering capacity. Administration of cumin seed caused a 
reduction in serum TC and also shows hypoglycemic effects, and similar 
findings were observed in the present study also. These findings are 
supported by another study in which administration of cumin seed 
powder capsule was reported to lower down the serum cholesterol as 
well as serum insulin level in diabetes Type-II suffering patients [25]. In 
another study, overweight patients showed a reduced level of serum TC, 
TG, and LDL-C [26]. Methanolic extract of cumin seed has been reported 
to exhibit the hypolipidemic effect in rats [27]. Besides this, the plant 
also has antioxidant activity with an antioxidant index of 1.3, due to 
the presence of the cuminic aldehyde, p-mentha-3-en-7-al, and several 
flavonoids reportedly apigenin7-o-glucoside, apigenin-5-o-glucoside, 
and luteolin-7-o-glucoside [28]. The mechanism of action of the drug 
may involve inhibition of HMG-CoA reductase enzyme or by inhibition of 
cholesterol absorption in the small intestine or the drug may have some 
anti-inflammatory and antiplatelet aggregation activity which stops 
plaque progression.
CONCLUSION
The present study proves that the plant C. cyminum L. has an anti-
atherosclerotic effect due to its capacity to reduce ox-LDL and LDL 
concentration in serum, and both the elements play a central role in 
developing atherosclerosis. The plant also possesses antioxidant, 
hypoglycemic, anticancerous, and carminative effect.
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Table 1: Serum lipid profile of cholesterol-fed rabbits treated with 70% EtOH of cumin seed extract
Treatment groups TC  
(mg/dl)








TC/HDL HDL/LDL Total lipid  
(mg/dl)
Group I: Intact control 79.8±9.63 27.3±2.01 11.11±1.36 19.46±1.67 80.16±6.01 2.92±0.31 2.45±0.2 388.71±30.16
Group II: Hyperlipidemic 
control
990.08±60.16c 112.9±11.16c 853.6±71.16c 35.44±4.76b 299.22±25.12c 10.63±1.63c 9.29±0.87c 2379.8±210.16c
Group III: Cumin seed 
extract
145.74±13.12b,g 34.26±5.01d,g 33.3±2.67c, g 21.4±2.61d,f 107.53±11.23a,g 4.2±0.33b,g 2.14±0.16d,g 599.01±70.12c,g
Group IV: Atorvastatin 113.35±9.01a,g 27.05±1.97d,g 24.69±2.06c,g 24.6±2.2a,e 173.45±13.79c,f 5.38±0.42c,f 0.33±0.01c.g 431.37±41.12d,
Values expressed as mean±SEM (n=5). Groups II to IV compared with Group I, where ap≤0.05, bp≤0.01, cp≤0.001 and dnon-significant=d. Groups III and IV are compared 
with Group II, where ep≤0.05, fp≤0.01, gp≤0.001 and hnon-significant=h. SEM: Standard error of the mean, TC: Total cholesterol, HDL: High-density lipoprotein, LDL: 
Low-density lipoprotein, VLDL: Very low-density lipoprotein, TGs: Triglycerides
Table 2: Serum biochemistry of cholesterol-fed rabbits treated with 70% EtOH of cumin seed extract
Biochemical parameters Group I: Intact 
control
Group II: Hyperlipidemic 
control.




Blood sugar (mg/dl) 89.5±8.76 118.4±15.12a 95.2±8.9d,h 102.6±10.14d,h
Blood urea (mg/dl) 46.05±3.66 82.3±8.76b 61±5.36a, e 51.9±4.33d,f
Creatinine (mg/dl) 0.81±0.07 1.25±0.16a 1.08±0.61d,h 1±0.18d,h
Uric acid (mg/dl) 3.7±0.3 2.05±0.21b 3.1±0.43d, f 5.02±0.36b,g
SGOT (U/L) 74.9±7.5 63.35±5.16a 85.91±8.75d,e 88.75±8.23b,f
SGPT (U/L) 71.5±7.5 75±8.12d 71.47±6.96d,h 152.35±14.21b,f
Bilirubin total (mg/dl) 1.06±0.01 0.63±0.06c 0.85±0.03c,f 0.72±0.06c,h
Alkaline phosphatase (U/L) 130.1±15.12 235.1±21.3b 71.47±6.96d,h 158.35±14.1d,f
Total protein (g/dl) 6.8±0.35 5.21±0.43b 6.57±0.55d,e 5.44±0.49b,h
Values expressed as mean±SEM (n=5). Groups II to IV compared with Group I, where ap≤0.05, bp≤0.01, cp≤0.001 and dnon-significant=d. Groups III and IV are compared 
with Group II, where ep≤0.05, fp≤0.01, gp≤0.001 and hnon-significant=h. SEM: standard error of the mean
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